Type 2 diabetes (T2D) research hub

The Attractive 2 trial – An open-label, randomised, 2-period cross-over trial to assess the pharmacokinetics of ATR-258 oral capsule vs. oral solution formulations in healthy volunteers

This study is testing a new medicine, ATR-258, for people with type 2 diabetes. We want to see how two different forms of the medicine (a capsule and a liquid) move through the body in healthy adult volunteers.